Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 22, 2021 - Issue 16: Pharmacotherapy for Diabetes and its complications
Submit an article Journal homepage
408
Views
9
CrossRef citations to date
0
Altmetric
Review

Careful use to minimize adverse events of oral antidiabetic medications in the elderly

André J. Scheena Division of Clinical Pharmacology, Centre for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium;b Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Liège, BelgiumCorrespondence[email protected]
Pages 2149-2165 | Received 03 Mar 2021, Accepted 31 Mar 2021, Published online: 13 Apr 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

André J. Scheen. (2023) The current role of SGLT2 inhibitors in type 2 diabetes and beyond: a narrative review. Expert Review of Endocrinology & Metabolism 18:4, pages 271-282.
Read now

Articles from other publishers (8)

André J. Scheen. (2023) Cardiovascular and renal outcomes with SGLT2 inhibitors: Real-life observational studies in older patients with type 2 diabetes. Diabetes Epidemiology and Management 10, pages 100135.
Crossref
Richard E Pratley, Christopher P Cannon, David Z I Cherney, Francesco Cosentino, Darren K McGuire, Margaret Noyes Essex, David Lawrence, Philip L S Jones, Jie Liu, Ingrid Adamsons & Samuel Dagogo-Jack. (2023) Cardiorenal outcomes, kidney function, and other safety outcomes with ertugliflozin in older adults with type 2 diabetes (VERTIS CV): secondary analyses from a randomised, double-blind trial. The Lancet Healthy Longevity 4:4, pages e143-e154.
Crossref
André J. Scheen. (2023) Clinical pharmacology of antidiabetic drugs: What can be expected of their use?. La Presse Médicale 52:1, pages 104158.
Crossref
André J. Scheen & Fabrice Bonnet. (2023) Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?. Diabetes & Metabolism 49:2, pages 101419.
Crossref
Rodrigo Quera, Paulina Núñez, Beatriz Sicilia, Lilian Flores & Fernando Gomollón. (2022) Corticoides en la enfermedad inflamatoria intestinal: ¿siguen siendo una opción terapéutica?. Gastroenterología y Hepatología.
Crossref
Rena Pollack & Avivit Cahn. (2022) SGLT2 Inhibitors and Safety in Older Patients. Heart Failure Clinics 18:4, pages 635-643.
Crossref
Thaer Idrees, Iris A Castro-Revoredo, Alexandra L Migdal, Emmelin Marie Moreno & Guillermo E Umpierrez. (2022) Update on the management of diabetes in long-term care facilities. BMJ Open Diabetes Research & Care 10:4, pages e002705.
Crossref
André J. Scheen. (2022) Choix entre une gliptine et une gliflozine chez le patient âgé avec un diabète de type 2. Médecine des Maladies Métaboliques 16:3, pages 264-270.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.